88484180 - XCOPRI

Information

  • Trademark
  • 88484180
  • Serial Number
    88484180
  • Registration Number
    6125911
  • Filing Date
    June 21, 2019
    5 years ago
  • Registration Date
    August 11, 2020
    4 years ago
  • Transaction Date
    November 27, 2024
    a month ago
  • Status Date
    August 11, 2020
    4 years ago
  • Published for Opposition Date
    February 11, 2020
    4 years ago
  • Location Date
    July 06, 2020
    4 years ago
  • First Use Anywhere Date
    May 11, 2020
    4 years ago
  • First Use In Commerce Date
    May 11, 2020
    4 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    AGREDA, SAMANTHA
  • Attorney Docket Number
    STP20240311
    Attorney Name
    Hun Joon Kim
    Law Office Assigned Location Code
    N50
  • Owners
Mark Drawing Code
3
Mark Identification
XCOPRI
Case File Statements
  • DM0000: The mark consists of the stylized word "XCOPRI" in purple upper case letters. The letter "O" contains a red circular design divided by a triangular ray, which extends past the letter "O". The remaining color white represents background and is not a feature of the mark.
  • GS0051: Medicines for human purposes and veterinary preparations for treatment of central nervous system diseases, cancer and metabolic diseases; biochemical preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; medical preparation of trace elements for human and animal use, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; biotechnological preparations for medical purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medicinal purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; chemical preparations for medical or veterinary purposes, namely, for the treatment of central nervous system diseases, cancer and metabolic diseases; pharmaceutical preparations for immunity adjustment; therapeutic drugs and agents for the treatment of central nervous system diseases, cancer and metabolic diseases; chemico-pharmaceutical preparations for the treatment of central nervous system diseases, cancer and metabolic diseases
  • CC0000: The colors purple and red are claimed as a feature of the mark.
Case File Event Statements
  • 9/12/2019 - 5 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/25/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/2/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/3/2019 - 5 years ago
    3 - NOTICE OF DESIGN SEARCH CODE E-MAILED Type: MDSC
  • 9/16/2019 - 5 years ago
    5 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 9/16/2019 - 5 years ago
    6 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 9/16/2019 - 5 years ago
    7 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 10/7/2019 - 5 years ago
    8 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/27/2019 - 5 years ago
    9 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 12/6/2019 - 5 years ago
    10 - ASSIGNED TO LIE Type: ALIE
  • 12/11/2019 - 5 years ago
    11 - ASSIGNED TO LIE Type: ALIE
  • 1/2/2020 - 4 years ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 12/23/2019 - 5 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 12/23/2019 - 5 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/22/2020 - 4 years ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/11/2020 - 4 years ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 5/11/2020 - 4 years ago
    21 - USE AMENDMENT FILED Type: IUAF
  • 2/11/2020 - 4 years ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/7/2020 - 4 years ago
    18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 5/11/2020 - 4 years ago
    19 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 5/28/2020 - 4 years ago
    22 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 5/28/2020 - 4 years ago
    20 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 7/6/2020 - 4 years ago
    23 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 7/7/2020 - 4 years ago
    24 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 8/11/2020 - 4 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 11/27/2024 - a month ago
    27 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 11/27/2024 - a month ago
    29 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 11/27/2024 - a month ago
    26 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 11/27/2024 - a month ago
    28 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR